Market Place
Sourcing Support
Genetic medicines biotech to cease operations by end of year
02 Nov 2023 //
FIERCE BIOTECH
Locanabio Announces Presentation of Data Showing an Improved Vectorized Platform
06 Oct 2023 //
GLOBENEWSWIRE
Locanabio Announces Participation in Chardan™s 7th Annual Conference
25 Sep 2023 //
GLOBENEWSWIRE
Locanabio Announces Equity Investment from CureDuchenne Ventures to Support Devp
15 May 2023 //
GLOBENEWSWIRE
Locanabio Announces Presentations at the ASGCT (ASGCT) 26th Annual Meeting
02 May 2023 //
GLOBENEWSWIRE
Locanabio Announces First Presentation of Data InvG LBIO-115 Program
20 Apr 2023 //
GLOBENEWSWIRE
Gene therapy startup Locanabio lays off staff, narrows focus on Duchenne
24 Feb 2023 //
ENDPTS
Locanabio to Present New PC Data Demonstrating Application of CORRECTx Platform
02 May 2022 //
PRNEWSWIRE
Locanabio Expands Leadership Team with Appointment of Kat Lange as CFO
07 Sep 2021 //
PRNEWSWIRE
Locanabio nabs CRISPR Tx in vivo head as CSO and Audentes` CMO
07 Jul 2021 //
FIERCEBIOTECH
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.